A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Spinal Elements Announces FDA 510(k) Clearance of Lucent® 3D Additive Manufactured Interbody Devices

What To Know

  •   The resulting Lucent 3D implant is comprised of a strut-and-lattice structure with a bone graft chamber access lid designed to allow the surgeon to deliver a large amount of tightly packed graft inside the interbody structure, maximizing the amount of graft material available for fusion.
  •   Spinal Elements was among the first companies to obtain interbody clearance for PEEK devices in 2005 and followed that in 2012 by being the first to apply Ti-Bond®, Spinal Elements' brand of plasma-sprayed titanium, on the surface of its PEEK interbody devices.

Spinal Elements, a spine technology company, today announced the first 510(k) clearance in the Lucent® 3D line of 3D-printed interbody devices.

Spinal Elements, in developing lucent 3D, has taken advantage of the unique capabilities of 3D printing by printing a functionally unique multi-component device in a single printing step.  The resulting Lucent 3D implant is comprised of a strut-and-lattice structure with a bone graft chamber access lid designed to allow the surgeon to deliver a large amount of tightly packed graft inside the interbody structure, maximizing the amount of graft material available for fusion. Furthermore, when the access lid to the graft chamber is closed, the lid is designed to help distribute the loads of the spine in order to reduce the incidence of subsidence by having more surface area available for load distribution.

 With the FDA clearance and upcoming release of the novel Lucent 3D system, Spinal Elements continues its long tradition of excellence and leadership in introducing novel design and materials science to interbody devices.  Spinal Elements was among the first companies to obtain interbody clearance for PEEK devices in 2005 and followed that in 2012 by being the first to apply Ti-Bond®, Spinal Elements’ brand of plasma-sprayed titanium, on the surface of its PEEK interbody devices.

“The FDA clearance of Lucent 3D allows Spinal Elements to differentiate itself in a crowded 3D-printed interbody market.  Lucent 3D’s novel design is meant to address the challenges surgeons have shared with us of other 3D-printed interbody devices – subsidence and the amount of bone graft material available for fusion,” stated President and CEO Jason Blain.  “We are thrilled to obtain this first clearance and look forward to building on this platform to complement our various procedural solutions.”

Spinal Elements is a technology-driven company headquartered in Carlsbad, California. A leading designer, developer, manufacturer and marketer of innovative medical devices used in spinal surgical procedures, Spinal Elements combines leading medical device technologies, biologics and instrumentation to create positive surgical outcomes that exceed surgeon and patient expectations. Spinal Elements has built a reputation delivering innovative and differentiated technologies that enable fundamental shifts in solutions for spine surgery. The company markets a complete portfolio of advanced spinal implant technologies.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy